The experts warn: “The virus also attacks the brain”
Source: la Repubblica
Covid, a young international team: that’s how Pomezia works on the vaccine
In an 80,000 m2 site 20 miles from Rome, young researchers from around the world work day and night making history. They have played a key role in the development of the Covid-19 vaccine, after the Jenner Institute (expert in…
La Vita in Diretta, Interview with Piero Di Lorenzo RAI 1 – 17th April
ALBERTO MATANO While we’re waiting for the Civil Protection Department to come on, I’d like to show you this important report produced by our very own Guido Schwarz. There is a lot of talk at the moment about a possible…
Interview with Piero Di Lorenzo. The Italian company. Enthusiasm in Rome: «But now we have to be cautious»
Source: Corriere della Sera
Positive results from initial clinical trials of Covid-19 vaccine AZD1222, manufactured by IRBM’s Advent
IRBM’s Advent, a global leader in viral vector manufacturing, has made thousands of doses of a novel Covid-19 vaccine, called AZD1222, for use by the University of Oxford and AstraZeneca in clinical trials in the UK, Brazil and South Africa.
Interview with Matteo Liguori: «Everything will depend on tests on subjects at risk»
Source: la Repubblica
TG 1, interview with Piero Di Lorenzo TG 1 – 15th April
TG1 PRESENTER We now have Piero Di Lorenzo on the line. He is the Managing Director of the company of Pomezia that developed the Coronavirus vaccine together with Oxford University. Good morning Mr. Di Lorenzo, what stage are we at…